$316.67
5.48%
NYSE, Apr 21, 07:45 pm CET
ISIN
US40412C1018
Symbol
HCA

HCA Stock price

$335.01
+6.55 1.99% 1M
-71.47 17.58% 6M
+34.86 11.61% YTD
+23.98 7.71% 1Y
+75.10 28.89% 3Y
+219.35 189.65% 5Y
+256.97 329.28% 10Y
NYSE, Closing price Thu, Apr 17 2025
+4.01 1.21%
ISIN
US40412C1018
Symbol
HCA
Sector

Key metrics

Market capitalization $82.48b
Enterprise Value $128.75b
P/E (TTM) P/E ratio 15.24
EV/FCF (TTM) EV/FCF 22.83
EV/Sales (TTM) EV/Sales 1.82
P/S ratio (TTM) P/S ratio 1.17
P/B ratio (TTM) P/B ratio negative
Dividend yield 0.79%
Last dividend (FY24) $2.64
Revenue growth (TTM) Revenue growth 8.67%
Revenue (TTM) Revenue $70.60b
EBIT (operating result TTM) EBIT $10.55b
Free Cash Flow (TTM) Free Cash Flow $5.64b
Cash position $2.02b
EPS (TTM) EPS $21.99
P/E forward 13.41
P/S forward 1.11
EV/Sales forward 1.73
Short interest 3.18%
Show more

Is HCA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

HCA Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a HCA forecast:

16x Buy
57%
11x Hold
39%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a HCA forecast:

Buy
57%
Hold
39%
Sell
4%

Financial data from HCA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
70,603 70,603
9% 9%
100%
- Direct Costs 60,056 60,056
9% 9%
85%
10,547 10,547
10% 10%
15%
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
13,859 13,859
9% 9%
20%
- Depreciation and Amortization 3,312 3,312
8% 8%
5%
EBIT (Operating Income) EBIT 10,547 10,547
10% 10%
15%
Net Profit 5,760 5,760
10% 10%
8%

In millions USD.

Don't miss a Thing! We will send you all news about HCA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

HCA Stock News

Neutral
Business Wire
11 days ago
NASHVILLE, Tenn. & ORANGE, Calif. & BOSTON--(BUSINESS WIRE)--Two large multi-state studies funded by the National Institutes of Health and led by the University of California, Irvine, Harvard Pilgrim Health Care Institute, and HCA Healthcare have found a highly effective method to improve antibiotic selection for patients who are hospitalized with abdominal or skin and soft tissue infection to ...
Neutral
Business Wire
14 days ago
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been named on Fortune's 2025 World's Most Admired Companies list. HCA Healthcare is ranked first overall in its industry. “It is an honor to be named a World's Most Admired Company by Fortune again this year,” said Sam Hazen, CEO of HCA Healthcare. “R...
Negative
The Motley Fool
14 days ago
Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies.
More HCA News

Company Profile

HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. The company was founded by Dr. Thomas Frist Sr., Dr. Thomas Frist Jr., and Jack Massey in 1968 and is headquartered in Nashville, TN.

Head office United States
CEO Samuel Hazen
Employees 316,000
Founded 1968
Website www.hcahealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today